- Home
- CEVA vs VSTM Comparison
CEVA vs VSTM Comparison
Compare CEVA & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEVA
- VSTM
- Stock Information
- Founded
- CEVA 1999
- VSTM 2010
- Country
- CEVA United States
- VSTM United States
- Employees
- CEVA N/A
- VSTM N/A
- Industry
- CEVA Semiconductors
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- CEVA Technology
- VSTM Health Care
- Exchange
- CEVA Nasdaq
- VSTM Nasdaq
- Market Cap
- CEVA 555.0M
- VSTM 598.2M
- IPO Year
- CEVA 2000
- VSTM 2012
- Fundamental
- Price
- CEVA $26.63
- VSTM $9.55
- Analyst Decision
- CEVA Strong Buy
- VSTM Strong Buy
- Analyst Count
- CEVA 5
- VSTM 9
- Target Price
- CEVA $35.60
- VSTM $13.38
- AVG Volume (30 Days)
- CEVA 243.7K
- VSTM 2.6M
- Earning Date
- CEVA 11-06-2025
- VSTM 11-05-2025
- Dividend Yield
- CEVA N/A
- VSTM N/A
- EPS Growth
- CEVA N/A
- VSTM N/A
- EPS
- CEVA N/A
- VSTM N/A
- Revenue
- CEVA $106,353,000.00
- VSTM $2,137,000.00
- Revenue This Year
- CEVA $4.35
- VSTM $88.50
- Revenue Next Year
- CEVA $15.50
- VSTM $398.66
- P/E Ratio
- CEVA N/A
- VSTM N/A
- Revenue Growth
- CEVA 7.71
- VSTM N/A
- 52 Week Low
- CEVA $18.31
- VSTM $2.54
- 52 Week High
- CEVA $38.94
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- CEVA 71.56
- VSTM 57.46
- Support Level
- CEVA $24.07
- VSTM $9.10
- Resistance Level
- CEVA $24.88
- VSTM $10.06
- Average True Range (ATR)
- CEVA 0.87
- VSTM 0.67
- MACD
- CEVA 0.34
- VSTM -0.17
- Stochastic Oscillator
- CEVA 88.58
- VSTM 25.55
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.